Results 181 to 190 of about 66,239 (358)
ACR Open Rheumatology, Volume 7, Issue 10, October 2025.Objective Antiphospholipid antibody (aPL) syndrome (APS) classification requires a thrombotic event and detection of lupus anticoagulant (LAC), anticardiolipin antibodies (aCL), or anti–β2‐glycoprotein I (anti‐β2GPI) antibodies on two occasions ≥12 weeks apart. Here, we investigated the utility of anti–phosphatidylserine/prothrombin complex (anti‐PS/PT)
Christina Donath +4 more
wiley +1 more source
ORAL, ONCE-DAILY RIVAROXABAN FOR THE PREVENTION OF SYMPTOMATIC VENOUS THROMBOEMBOLISM AFTER MAJOR ORTHOPAEDIC SURGERY: A META-ANALYSIS OF THREE PIVOTAL STUDIES [PDF]
, 2008 Alexander G.G. Turpie +8 more
openalex +1 more source
Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia
American Journal of Hematology, Volume 100, Issue 10, Page 1722-1735, October 2025.ABSTRACT Hereditary hemorrhagic telangiectasia (HHT) is the second‐most common inherited bleeding disorder worldwide, afflicting one in 4000–5000 people, and is the most morbid inherited bleeding disorder of women. HHT causes recurrent severe epistaxis, chronic gastrointestinal bleeding, heavy menstrual bleeding, and arteriovenous malformations in the ...
Hanny Al‐Samkari +5 more
wiley +1 more source
The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence
Brain and Behavior, Volume 15, Issue 10, October 2025.This study delineates the multiple pathways leading to stroke, encompassing genetic risk factors such as lipid/cholesterol metabolism, blood pressure regulation genes, and endothelial dysfunction. The report includes genetic pathways such as Val66Met polymorphism, prothrombin G20210A, interleukin‐6 and tumor necrosis factor gene variant, along with ...
Mega Obukohwo Oyovwi +3 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2770-2780, October 1, 2025.ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye +19 more
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Although cerebral venous thrombosis and stroke are rare extra‐intestinal manifestations of Ulcerative colitis, if present, they increase the risk for morbidity and mortality. As such, physicians dealing with a case of Ulcerative colitis should always be vigilant about the potential for venous or arterial thrombosis.
Niranjan KC +4 more
wiley +1 more source
Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer’s perspective [PDF]
, 2011 A Alvarado Duran +5 more
openalex +1 more source
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Peripartum cardiomyopathy (PPCM) is a rare form of heart failure occurring during late pregnancy or within 5 months postpartum, its etiology remaining elusive. While typically characterized by left ventricular dysfunction, it may present with intracardiac thrombi, raising the risk of systemic embolization.
Gidion Edwin +3 more
wiley +1 more source
Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model [PDF]
, 2011 Anne Godiér +8 more
openalex +1 more source